Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022
[153 Pages Report] The global bone growth stimulator market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period. The growing patient preference for non-invasive and minimally invasive surgical treatments, increasing target patient population, and procedural benefits offered by bone stimulation devices in bone fracture treatments are some key factors propelling the growth of this market. However, limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products may hinder the growth of this market during the forecast period.
Market Dynamics
Drivers
- Growing patient preference for noninvasive and minimally invasive surgical treatments
- Increasing target patient population
- Procedural benefits offered by bone stimulation devices in bone fracture treatment
Restraints
- Limited medical reimbursement for bone stimulation products
- High treatment costs associated with BMP and PRP products
Opportunity
- Emerging markets
Challenges
- Lawsuits filed against major market players affecting the brand value
- Side effects associated with BMP-based orthopedic treatment
Procedural benefits offered by bone stimulation devices in bone fracture treatment
Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures. These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections. This is expected to aid the adoption of bone growth stimulation products among key end users. This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.
As of 2015, the average treatment cost saving for diabetes patients in the U.S. being treated with electrical bone growth stimulation (EBGS) devices was reported to be ~USD 4,800 and USD 3,000 as compared to non-stimulation based treatment and low-intensity pulsed ultrasound stimulation (LIPUS) treatment, respectively (Source: Journal of Diabetes & Metabolism, 2013). Similarly, a research study was undertaken among adult patients diagnosed with a nonunion bone fracture between July 2006 and September 2009 in the U.S. This research study estimates the per patient healthcare expenditure for nonunion fractures treatment with EBGS devices to be USD 21,632 as compared to USD 23,843 and USD 23,964 for non-stimulation based treatment and LIPUS treatment, respectively (Source: Orthopedic Research and Reviews, 2013). Significant cost advantages offered by these devices is expected to further drive their market demand in the coming years.
The following are the major objectives of the study
- To define, describe, and forecast the global bone growth stimulator market on the basis of product, application, and end user
- To provide detailed information regarding major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To strategically analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the total market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To provide market size for various segments of the bone growth stimulator market with respect to four main geographies, namely, North America (U.S. and Canada), Europe (Germany, France, the U.K., and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and Rest of the World
- To strategically profile the key players and comprehensively analyze their market shares and core competencies2 in the global bone growth stimulator industry
- To track and analyze competitive developments such as product launches, agreements, partnerships, mergers & acquisitions, and research and development activities in the global bone growth stimulator market
During this research study, major players operating in the bone growth stimulator market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents. The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) pertaining to the market. The figure below shows the breakdown of the primaries on the basis of the company type, designation, and region considered during the research study.
To know about the assumptions considered for the study, download the pdf brochure
Orthofix International N.V. (U.S.), Medtronic plc (Ireland), and Zimmer Biomet Holdings, Inc. (U.S.) are some of the key players in the bone growth stimulators market. Over the past three years, these players have adopted product launches & enhancements, strategic acquisitions, and market expansions as their core business strategies to ensure dominance in this market. DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) were few other key players operating in the market.
Major Market Developments:
- In 2017, Orthofix International N.V. received CE and FDA approval for its next-generation bone growth stimulators, namely, Cervical-Stim and Spinal- Stim. These devices are used to stimulate and enhance natural healing process of the body post spinal fusion operation.
- In 2016, Bioventus LLC, launched its Ultrasound Bone Healing System, EXOGEN in Saudi Arabia. The product is used in the treatment of delayed unions, non-unions, and joint fusion
- In 2015, Zimmer Holdings merged with Biomet, Inc., a U.S.-based company engaged in the development of musculoskeletal medical products. This merger helped both companies to expand their footprints in the global musculoskeletal devices market and strengthen its position in the bone stimulators market.
Target Audience
- Bone growth stimulation products manufacturing companies
- Healthcare institutions (hospitals and outpatient clinics)
- Distributors and suppliers
- Research laboratories and academic institutions
- Government and regulatory authorities
- Non-government and other associations/organizations
- Market research and consulting firms
- Contract research organizations (CROS) and contract manufacturing organizations (CMOS)
Scope of the report
This research report categorizes the bone growth stimulator market into the following segments:
Bone Growth Stimulator Market, by Product
- Bone Growth Stimulation Devices
- External Bone Growth Stimulators
- Combined Magnetic Field (CMF) Devices
- Capacitive Coupling (CC) Devices
- Pulsed Electromagnetic Field (PEMF) Devices
- Implanted Bone Growth Stimulators
- Ultrasonic Bone Growth Stimulators
- Bone Morphogenetic Proteins (BMP)
- Platelet-rich Plasma (PRP)
Bone Growth Stimulator Market, by End User
- Hospitals and Clinics
- Home Care
- Academic & Research Institutes and CROs
Bone Growth Stimulators Market, by Application
- Spinal Fusion Surgeries
- Delayed Union & Nonunion Bone Fractures
- Oral and Maxillofacial Surgeries
- Other Applications
Bone Growth Stimulator Market, by Region
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- RoE
- Asia-Pacific
- Japan
- China
- India
- RoAPAC
- Rest of the World
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the bone growth stimulator market report:
Product Analysis
- Product Matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
Growing patient preference for noninvasive and minimally invasive surgical treatments and increasing target patient population are the key factors driving the growth of the global bone growth stimulator market. Furthermore, procedural benefits offered by bone stimulation devices are also fueling the market growth.
Bone growth stimulators include the medical devices (external and internal bone growth stimulators) and biologics (PRP and BMP); that are used during or post or after orthopedic treatments related to bone regeneration (including spine fusion surgery, bone fractures, and bone grafts, among others) in order to enhance the bone healing process.
On the basis of product, the global bone growth stimulator market is segmented into bone growth stimulation devices, bone morphogenetic protein (BMPs), and platelet-rich plasma (PRP). The bone growth stimulation devices segment is expected to account for the largest market share in 2016. This can primarily be attributed to the growing aging population globally, rising preference for non-surgical treatment procedures, and growing prevalence of nonunion fractures.
On the basis of application, the global bone growth stimulators market is segmented into spinal fusion surgeries, delayed union and nonunion bone fractures, dental and maxillofacial surgeries, and other applications. The spinal fusion surgeries segment is expected to grow at the highest CAGR during 2017 to 2022, owing to the growing geriatric population, rising number of spine procedures (and rate of spinal fusion failure), established safety and efficacy of stimulators in fusion surgery, and increasing use of bone growth stimulation products.
On the basis of end user, the global bone growth stimulators market is segmented into hospitals & clinics, home care, and academic & research institutes and CROs. In 2016, the hospitals & clinics segment accounted for the largest of the market. The advantages of bone growth stimulation products over their counterparts are the key factor driving their adoption in this end-user segment.
The market is dominated by North America, followed by Europe, Asia, and the Rest of the World. North America is expected to dominate the market in 2016. Asia is expected to grow at a highest CAGR during the forecast period. Factors such as large population base, improving healthcare infrastructure and the rising prevalence of obesity and spinal disorders are key factors driving market growth in the Asia-Pacific region.
Hospitals and Clinics Form the Fastest Growing End User Segment.
Hospitals
This segment includes both government and private hospitals that provide treatment or conduct surgeries related to spine, oral and maxillofacial, nonunion/delayed union fractures and dental practices. An increasing patient population, rising procedural volumes of spinal fusion surgeries, growing prevalence of spinal disorders, and growing awareness on bone growth stimulation products are aiding the growth of this segment.
Home care
Home care end users segment include patients who use external bone growth stimulators based on a physician’s prescription. Physicians recommend these stimulators to patients who have undergone spinal fusion surgery or are suffering from bone fractures that have failed to heal in the normal period of time (delayed or nonunion fracture). This segment is expected to witness growth due to rising physician preference for bone growth stimulators over their counterparts, cost-effectiveness of external stimulators in the case of nonunion fractures, government recommendations for the use of external stimulators, and the availability of reimbursement and insurance coverage.
Academic & Research Institutes and CROs
This end-user segment mainly uses bone growth stimulation products for research purposes. Growing research activity related to bone growth stimulation products to expand their applications and establish their clinical efficacy is the key factor driving the growth of this end-user segment.
Critical questions the report answers:
- What are the key growth strategies adopted by major global players to strengthen their market position across emerging and established regions?
- Greater clinical applications of PRP kits for early orthopedic recovery is an emerging market trend. What revenue impact will it have in the coming years on the overall bone growth stimulator industry?
- Emerging countries have immense opportunities for the growth of bone growth stimulators, will this scenario continue?
Limited availability of medical reimbursements for bone growth stimulation products and High treatment costs associated with BMP and PRP products are expected to restrain the growth of the bone growth stimulators market in the coming years.
Orthofix International N.V. (U.S.), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (U.S.), DJO Finance LLC (U.S.), Bioventus LLC (U.S.), Stryker Corporation (U.S.), DePuy Synthes (U.S.), Arthrex, Inc. (U.S.), Isto Biologics (U.S.), and Harvest Technologies Corporation (U.S.) are some of the players operating the bone growth stimulators market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
Table of Contents
1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.3 Market Size Estimation Methodology
2.3 Opportunity Indicators
2.3.1.1 Rapid Growth in the Geriatric Population
2.3.1.2 Healthcare Expenditure Patterns
2.3.1.3 Significant Number of Road Accidents
2.4 Market Data Validation and Triangulation
2.4.1 Assumptions for the Study
3 Executive Summary (Page No. - 29)
4 Premium Insights (Page No. - 34)
4.1 Bone Growth Stimulators: Market Snapshot (2017–2022)
4.2 Geographic Analysis: Bone Growth Stimulator Market, By Type (2017)
4.3 Global Bone Growth Stimulator Market, By Application, 2017 vs 2022
4.4 Global Market Size, By End User, 2017 vs 2022 (USD Million)
4.5 Market: Geographic Growth Opportunities
5 Market Overview (Page No. - 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Major Market Drivers
5.2.1.1 Growing Patient Preference for Noninvasive and Minimally Invasive Surgical Treatments
5.2.1.2 Increasing Target Patient Population
5.2.1.3 Procedural Benefits Offered By Bone Stimulation Devices in Bone Fracture Treatment
5.2.2 Major Market Restraints
5.2.2.1 Limited Medical Reimbursement for Bone Stimulation Products
5.2.2.2 High Treatment Costs Associated With BMP and PRP Products
5.2.3 Major Market Opportunities
5.2.3.1 Emerging Markets
5.2.4 Major Market Challenges
5.2.4.1 Lawsuits Filed Against Major Market Players Affecting the Brand Value
5.2.4.2 Side Effects Associated With BMP-Based Orthopedic Treatment
6 Industry Trends (Page No. - 44)
6.1 Introduction
6.2 Key Industry Trends
6.2.1 Off-Label Use of BMP Products
6.2.2 Increasing Use of PRP in Other Applications
6.3 Supply Chain Analysis
6.4 Porter’s Five Forces Analysis
7 Global Bone Growth Stimulator Market, By Product (Page No. - 47)
7.1 Introduction
7.2 Bone Growth Stimulation Devices
7.2.1 External Bone Growth Stimulators
7.2.1.1 Pulsed Electromagnetic Field Devices
7.2.1.2 Capacitive Coupling Devices
7.2.1.3 Combined Magnetic Field Devices
7.2.2 Implanted Bone Growth Stimulators
7.2.3 Ultrasonic Bone Growth Stimulators
7.3 Bone Morphogenetic Proteins
7.4 Platelet-Rich Plasma
8 Global Bone Growth Stimulator Market, By Application (Page No. - 59)
8.1 Introduction
8.2 Spinal Fusion Surgeries
8.3 Delayed Union & Nonunion Bone Fractures
8.4 Oral and Maxillofacial Surgeries
8.5 Other Applications
9 Global Bone Growth Stimulator Market, By End User (Page No. - 65)
9.1 Introduction
9.2 Hospitals & Clinics
9.3 Home Care
9.4 Academic & Research Institutes and CROS
10 Global Bone Growth Stimulator Market, By Region (Page No. - 70)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia-Pacific
10.5 Rest of the World
11 Competitive Landscape (Page No. - 104)
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovators
11.2.3 Dynamic Players
11.2.4 Emerging Players
11.3 Competitive Benchmarking
11.3.1 Product Offerings (For 23 Players)
11.3.2 Business Strategy (For 23 Players)
12 Company Profiles (Page No. - 108)
12.1 Top Market Players
12.1.1 Orthofix International N.V.
12.1.1.1 Overview
12.1.1.2 Company Scorecard
12.1.1.2.1 Product Offerings
12.1.1.2.2 Business Strategy
12.1.1.3 Recent Developments (2013-2017)
12.1.1.3.1 Product Launches, Enhancements, and Approvals
12.1.1.3.2 Other Developments
12.1.2 DJO Finance LLC
12.1.2.1 Overview
12.1.2.2 Company Scorecard
12.1.2.2.1 Product Offerings
12.1.2.2.2 Business Strategy
12.1.3 Zimmer Biomet Holdings, Inc.
12.1.3.1 Overview
12.1.3.2 Company Scorecard
12.1.3.2.1 Product Offerings
12.1.3.2.2 Business Strategy
12.1.3.3 Recent Developments (2013-2017)
12.1.3.3.1 Mergers & Acquisitions
12.1.4 Bioventus LLC
12.1.4.1 Overview
12.1.4.2 Company Scorecard
12.1.4.2.1 Product Offerings
12.1.4.2.2 Business Strategy
12.1.4.3 Recent Developments (2013-2017)
12.1.4.3.1 Product Launches, Showcases, Enhancements, and Recognitions
12.1.4.3.2 Mergers & Acquisitions
12.1.4.3.3 Expansions
12.1.4.3.4 Agreements
12.1.5 Medtronic PLC
12.1.5.1 Overview
12.1.5.2 Company Scorecard
12.1.5.2.1 Product Offerings
12.1.5.2.2 Business Strategy
12.1.5.3 Recent Developments (2013-2017)
12.1.5.3.1 Product Launches, Enhancements, and Approvals
12.1.5.3.2 Expansion
12.1.6 Stryker Corporation
12.1.6.1 Overview
12.1.6.2 Company Scorecard
12.1.6.2.1 Product Offerings
12.1.6.2.2 Business Strategy
12.1.7 Depuy Synthes (A Subsidiary of Johnson & Johnson)
12.1.7.1 Overview
12.1.7.2 Company Scorecard
12.1.7.2.1 Product Offerings
12.1.7.2.2 Business Strategy
12.1.7.3 Recent Developments (2013-2017)
12.1.7.3.1 Product Launches, Enhancements, and Approvals
12.1.8 Arthrex, Inc.
12.1.8.1 Overview
12.1.8.2 Company Scorecard
12.1.8.2.1 Product Offerings
12.1.8.2.2 Business Strategy
12.1.8.3 Recent Developments (2013-2017)
12.1.8.3.1 Expansion
12.1.9 Isto Biologics
12.1.9.1 Overview
12.1.9.2 Company Scorecard
12.1.9.2.1 Product Offerings
12.1.9.2.2 Business Strategy
12.1.9.3 Recent Developments (2013-2017)
12.1.9.3.1 Acquisitions
12.1.10 Harvest Technologies (A Terumo BCT Company)
12.1.10.1 Overview
12.1.10.2 Company Scorecard
12.1.10.2.1 Product Offerings
12.1.10.2.2 Business Strategy
12.2 Emerging Market Players
12.2.1 Ossatec Benelux Ltd.
12.2.1.1 Overview
12.2.1.2 Company Scorecard
12.2.1.2.1 Product Offerings
12.2.1.3 Business Strategy
12.2.2 Ember Therapeutics Inc.
12.2.2.1 Overview
12.2.2.2 Company Scorecard
12.2.2.2.1 Product Offerings
12.2.2.3 Business Strategy
12.2.2.4 Recent Developments (2013-2017)
12.2.2.4.1 Mergers & Acquisitions
12.2.3 Regen Lab SA
12.2.3.1 Overview
12.2.3.2 Company Scorecard
12.2.3.2.1 Product Offerings
12.2.3.3 Business Strategy
12.2.4 Altis Biologics (Pty) Ltd.
12.2.4.1 Overview
12.2.4.2 Company Scorecard
12.2.4.2.1 Product Offerings
12.2.4.2.2 Business Strategy
12.2.5 ITO Co., Ltd.
12.2.5.1 Overview
12.2.5.2 Company Scorecard
12.2.5.2.1 Product Offerings
12.2.5.2.2 Business Strategy
13 Appendix (Page No. - 145)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
List of Tables (66 Tables)
Table 1 Global Bone Growth Stimulators Market Size, By Product, 2015–2022 (USD Million)
Table 2 Global Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 3 Global Bone Growth Stimulation Devices Market Size, By Region, 2015–2022 (USD Million)
Table 4 External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 5 External Bone Growth Stimulators Market Size, By Region, 2015–2022 (USD Million)
Table 6 PEMF Devices Market Size, By Region, 2015–2022 (USD Million)
Table 7 CC Devices Market Size, By Region, 2015–2022 (USD Million)
Table 8 CMF Devices Market Size, By Region, 2015–2022 (USD Million)
Table 9 Implanted Bone Growth Stimulator Market Size, By Region, 2015–2022 (USD Million)
Table 10 Ultrasonic Bone Growth Stimulators Market Size, By Region, 2015–2022 (USD Million)
Table 11 Bone Morphogenetic Proteins Market Size, By Region, 2015–2022 (USD Million)
Table 12 Platelet-Rich Plasma Market Size, By Region, 2015–2022 (USD Million)
Table 13 Global Bone Growth Stimulator Market Size, By Application, 2015–2022 (USD Million)
Table 14 Market Size for Spinal Fusion Surgeries, By Region, 2015–2022 (USD Million)
Table 15 Market Size for Delayed Union and Nonunion Bone Fractures, By Region, 2015–2022 (USD Million)
Table 16 Market Size for Oral and Maxillofacial Surgeries, By Region, 2015–2022 (USD Million)
Table 17 Market Size for Other Applications, By Region, 2015–2022 (USD Million)
Table 18 Global Bone Growth Stimulator Market Size, By End User, 2015-2022 (USD Million)
Table 19 Global Market Size for Hospitals & Clinics, By Region, 2015-2022 (USD Million)
Table 20 Global Market Size for Home Care, By Region, 2015-2022 (USD Million)
Table 21 Global Market Size for Academic & Research Institutes and CROS, By Region, 2015-2022 (USD Million)
Table 22 Global Bone Growth Stimulator Market Size, By Region, 2015–2022 (USD Million)
Table 23 Market Size, By Country, 2015–2022 (USD Million)
Table 24 North America: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 25 North America: Market Size, By Product, 2015–2022 (USD Million)
Table 26 North America: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 27 North America: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 28 North America: Market Size, By End User, 2015–2022 (USD Million)
Table 29 North America: Market Size, By Application, 2015–2022 (USD Million)
Table 30 U.S.: Market Size, By Product, 2015–2022 (USD Million)
Table 31 U.S.: Market Size, By Application, 2015–2022 (USD Million)
Table 32 Canada: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 33 Canada: Market Size, By Application, 2015–2022 (USD Million)
Table 34 Europe: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 35 Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 36 Europe: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 37 Europe: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 38 Europe: Market Size, By End User, 2015–2022 (USD Million)
Table 39 Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 40 Germany: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 41 Germany: Market Size, By Application, 2015–2022 (USD Million)
Table 42 U.K.: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 43 U.K.: Market Size, By Application, 2015–2022 (USD Million)
Table 44 France: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 45 France: Market Size, By Application, 2015–2022 (USD Million)
Table 46 Rest of Europe: Market Size, By Product, 2015–2022 (USD Million)
Table 47 Rest of Europe: Market Size, By Application, 2015–2022 (USD Million)
Table 48 Asia-Pacific: Bone Growth Stimulator Market Size, By Country, 2015–2022 (USD Million)
Table 49 Asia-Pacific: Market Size, By Product, 2015–2022 (USD Million)
Table 50 Asia-Pacific: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 51 Asia-Pacific: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 52 Asia-Pacific: Market Size, By End User, 2015–2022 (USD Million)
Table 53 Asia-Pacific: Market Size, By Application, 2015–2022 (USD Million)
Table 54 Japan: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 55 Japan: Market Size, By Application, 2015–2022 (USD Million)
Table 56 China: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 57 China: Market Size, By Application, 2015–2022 (USD Million)
Table 58 India: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 59 India: Market Size, By Application, 2015–2022 (USD Million)
Table 60 RoAPAC: Market Size, By Product, 2015–2022 (USD Million)
Table 61 RoAPAC: Market Size, By Application, 2015–2022 (USD Million)
Table 62 RoW: Bone Growth Stimulator Market Size, By Product, 2015–2022 (USD Million)
Table 63 RoW: Bone Growth Stimulation Devices Market Size, By Type, 2015–2022 (USD Million)
Table 64 RoW: External Bone Growth Stimulator Market Size, By Type, 2015–2022 (USD Million)
Table 65 RoW: Market Size, By End User, 2015–2022 (USD Million)
Table 66 RoW: Market Size, By Application, 2015–2022 (USD Million)
List of Figures (67 Figures)
Figure 1 Global Bone Growth Stimulators Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Research Methodology: Top-Down Approach
Figure 5 Research Methodology: Bottom-Up Approach
Figure 6 Geriatric Population, By Region, 2015 vs 2030 vs 2050 (Million)
Figure 7 Healthcare Expenditure Across Major Countries, 2000–2014
Figure 8 Healthcare Expenditure Across Major Regions, 2000–2014
Figure 9 Number of Road Accidents Worldwide, 2010 vs 2014
Figure 10 Data Triangulation Methodology
Figure 11 Bone Growth Stimulators Market Size, By Product (2017 vs 2022)
Figure 12 Bone Growth Stimulation Devices Market Size, By Type (2017 vs 2022)
Figure 13 Bone Growth Stimulator Market Share, By End User (2017 vs 2022)
Figure 14 Market Size, By Application (2017 vs 2022)
Figure 15 Market Share, By Region (2016)
Figure 16 Increasing Target Patient Population—Primary Growth Driver of the Market
Figure 17 U.S. Commanded the Largest Share of the Bone Growth Stimulator Market in 2017
Figure 18 Spinal Fusion Surgeries Segment Will Continue to Dominate the Bone Growth Stimulator Market in 2022
Figure 19 Hospitals & Clinics Segment to Account for the Largest Share of the Global Bone Growth Stimulator Market in 2017
Figure 20 India and China are Lucrative Markets for Manufacturers of Bone Growth Stimulators
Figure 21 Supply Chain Analysis: Bone Growth Stimulators Industry (2016)
Figure 22 Market: Porter’s Five Forces Analysis (2016)
Figure 23 PRP, the Fastest-Growing Segment of the Global Market
Figure 24 Spinal Fusion Surgeries, the Fastest-Growing Application Segment of the Global Market
Figure 25 Hospitals & Clinics to Be the Fastest-Growing End-User Segment in the Global Bone Growth Stimulator Market
Figure 26 Asia-Pacific to Offer High Growth Potential in the Global Bone Growth Stimulators Market
Figure 27 North America: Market Snapshot
Figure 28 Europe: Market Snapshot
Figure 29 Asia-Pacific: Market Snapshot
Figure 30 Dive Chart
Figure 31 Orthofix International N.V.: Company Snapshot (2015)
Figure 32 Orthofix International N.V.: Product Offering Scorecard
Figure 33 Orthofix International N.V.: Business Strategy Scorecard
Figure 34 DJO Finance LLC: Company Snapshot (2015)
Figure 35 DJO Finance LLC: Product Offering Scorecard
Figure 36 DJO Finance LLC : Business Strategy Scorecard
Figure 37 Zimmer Biomet Holdings, Inc.: Company Snapshot (2015)
Figure 38 Zimmer Biomet Holdings, Inc.: Product Offering Scorecard
Figure 39 Zimmer Biomet Holdings, Inc.: Business Strategy Scorecard
Figure 40 Bioventus LLC: Product Offering Scorecard
Figure 41 Bioventus LLC: Business Strategy Scorecard
Figure 42 Medtronic PLC: Company Snapshot (2016)
Figure 43 Medtronic PLC: Product Offering Scorecard
Figure 44 Medtronic PLC: Business Strategy Scorecard
Figure 45 Stryker Corporation: Company Snapshot (2015)
Figure 46 Stryker Corporation: Product Offering Scorecard
Figure 47 Stryker Corporation: Business Strategy Scorecard
Figure 48 Johnson & Johnson: Company Snapshot (2016)
Figure 49 Johnson & Johnson: Product Offering Scorecard
Figure 50 Johnson & Johnson: Business Strategy Scorecard
Figure 51 Arthrex, Inc.: Product Offering Scorecard
Figure 52 Arthrex, Inc.: Business Strategy Scorecard
Figure 53 Isto Biologics: Product Offering Scorecard
Figure 54 Isto Biologics: Business Strategy Scorecard
Figure 55 Terumo Corporation: Company Snapshot (2015)
Figure 56 Terumo Corporation: Product Offering Scorecard
Figure 57 Terumo Corporation: Business Strategy Scorecard
Figure 58 Ossatec Benelux Ltd.: Product Offering Scorecard
Figure 59 Ossatec Benelux Ltd.: Business Strategy Scorecard
Figure 60 Ember Therapeutics, Inc.: Product Offering Scorecard
Figure 61 Ember Therapeutics, Inc.: Business Strategy Scorecard
Figure 62 Regen Lab SA: Product Offering Scorecard
Figure 63 Regen Lab SA: Business Strategy Scorecard
Figure 64 Altis Biologics (Pty) Ltd.: Product Offering Scorecard
Figure 65 Altis Biologics (Pty) Ltd.: Business Strategy Scorecard
Figure 66 ITO Co., Ltd: Product Offering Scorecard
Figure 67 ITO Co., Ltd: Business Strategy Scorecard
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Bone Growth Stimulator Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Bone Growth Stimulator Market